v1
Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.
Identifier:nobleid.org/w1/20260515/1283AF8F
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/1283AF8F)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims